Wael Khoury, MD

Leading the Cardiology program at Marymount since 1982.

Lobbied the ODH and the State of Ohio to allow Hospitals less than 250 beds to have a level one diagnostic cardiac cath labs. 25 Hospitals in Ohio opened up cath. labs, 4 of them are in the Cleveland Clinic System.

Working with Dr. James Young on the CHF CCF Ad Hoc committee we received the Codman Award by the joint Commission in 2001, which was the first of its kind to a large hospital system in the US.

I spear headed and established a CCHS CRO for the East side Hospitals, 2002-2011. Several Clinical research projects went through the CRO for several years. It was then folded into the CCF CRO.

Working with Dr. Randall Starling, we initiated an Ad Hoc committee to establish the H to H program for CCHS. It then got folded into the general Quality Improvement programs of the system.

As the CMO at that time, I was on the early negotiation steps that lead to Marymount joining the Cleveland Clinic in 1995. I played an active part in the process.

Consequently, I was a member of the Medical Operations Council of CCHS for many years, even after changing its name and structure, up to 2017.

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-02-25, Dr. Khoury has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.